The advent of nanomedicines allows a diversity of drugs with unfavorable
biopharmaceutical properties and safety issues to be accessible as pharmaceutical
products. The expectations are particularly high in the field of cancer therapeutics,
where nanotechnology promises to enhance treatment selectivity, solving or
ameliorating off-target toxicity issues. The biocompatible nature of lipid-based
nanosystems and their scalable production make them especially auspicious for
therapeutic applications.
Here, we present an update on recent patents on lipid-based nanosystems (liposomes,
solid lipid nanoparticles and nano-structured lipid carriers) applications to cancer
therapy.
Keywords: Anticancer drugs, biopharmaceutics, cancer, cancer therapy, lipidbased
nanosystems, liposomes, multifunctional nanosystems, nanomedicine,
nanostructured lipid carriers, nanosystems, nanotechnology, patents,
pharmacokinetics, pharmaceutical nanocarriers, smart delivery, solid lipid
nanocarriers, stimuli-responsive systems, targeted drug delivery.
